A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases.

about

A New Perspective: Mitochondrial Stat3 as a Regulator for Lymphocyte Function.Targeting in neutrophils enhances the clearance of in infected wounds

P2860

Q55562159-814E3993-9DE1-446B-910D-04A21C40B3F0 Q58778684-DD90183F-EA6C-4DFB-8091-4AB193F3544E

P2860

A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases.

Item

http://www.wikidata.org/entity/Q52675492

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases.

@en

A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases.

@nl

type

Item

label

A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases.

@en

A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases.

@nl

prefLabel

A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases.

@en

A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases.

@nl

P1476

A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases.

@en

P2093

Andrea Rubbert-Roth

http://www.w3.org/2001/XMLSchema#string

Angela Jin

http://www.w3.org/2001/XMLSchema#string

Daniel E Furst

http://www.w3.org/2001/XMLSchema#string

Erhan Berber

http://www.w3.org/2001/XMLSchema#string

Jan Michael Nebesky

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study

Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)

Comparative Effectiveness of Biologic Therapy Regimens for Ankylosing Spondylitis: A Systematic Review and a Network Meta-Analysis

Clinical practice. Giant-cell arteritis and polymyalgia rheumatica

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic dr

Incidence of Gastrointestinal Perforations in Patients with Rheumatoid Arthritis Treated with Tocilizumab from Clinical Trial, Postmarketing, and Real-World Data Sources

Systematic review of tocilizumab for rheumatoid arthritis: a new biologic agent targeting the interleukin-6 receptor.

Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity.

Th17 and Th1 T-cell responses in giant cell arteritis.

Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs

P2888

s40744-018-0102-x

P304

21-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40744-018-0102-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29502236

http://www.w3.org/2001/XMLSchema#string

P932

5935615

http://www.w3.org/2001/XMLSchema#string

A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases.

about

P2860

P2860

A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P932